Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Klesse

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
CNS Drugs|March 20, 2010
Childhood medulloblastoma: current status of biology and treatmentLaura J Klesse, Daniel C Bowers
Cancers|December 10, 2021
Targeted Therapies for the NeurofibromatosesLauren D Sanchez, Ashley Bui, Laura J Klesse
The Journal of Investigative Dermatology|August 17, 2010
Cutaneous features predict paraspinal neurofibromas in neurofibromatosis type 1Rebecca M Brown, Laura J Klesse, Lu Q Le
Journal of Neuroscience Research|July 12, 2002
BDNF activated TrkB/IRR receptor chimera promotes survival of sympathetic neurons through Ras and PI-3 kinase signalingKaren S Kelly-Spratt, Laura J Klesse, Luis F Parada
Molecular and Cellular Neurosciences|February 22, 2003
Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factorsRomke Bron, Laura J Klesse, Kirti Shah, et al.
JID Innovations : Skin Science From Molecules to Population Health|October 4, 2021
Insights into the Pathogenesis of NF1-Associated NeoplasmsAshley Bui, Chunhui Jiang, Renee M McKay, et al.
Journal of Neuro-Oncology|August 10, 2016
Postoperative surveillance of pediatric cerebellar pilocytic astrocytomaRaphael Alford, Lynn Gargan, Daniel C Bowers, et al.
Children (Basel, Switzerland)|March 6, 2021
Risk Factors for Bullying Victimization in Children with Neurofibromatosis Type 1 (NF1)Peter L Stavinoha, Cody Solesbee, Susan M Swearer, et al.
CA: a Cancer Journal for Clinicians|April 1, 2021
Recent progress in the treatment of cancer in childrenErin Butler, Kathleen Ludwig, Holly L Pacenta, et al.
School Psychology (Washington, D.C.)|November 8, 2019
Rate and frequency of bullying victimization in school-age children with neurofibromatosis type 1 (NF1)Alice Ann Holland, Peter L Stavinoha, Susan M Swearer, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
CNS Drugs|March 20, 2010
Childhood medulloblastoma: current status of biology and treatmentLaura J Klesse, Daniel C Bowers
Cancers|December 10, 2021
Targeted Therapies for the NeurofibromatosesLauren D Sanchez, Ashley Bui, Laura J Klesse
The Journal of Investigative Dermatology|August 17, 2010
Cutaneous features predict paraspinal neurofibromas in neurofibromatosis type 1Rebecca M Brown, Laura J Klesse, Lu Q Le
Journal of Neuroscience Research|July 12, 2002
BDNF activated TrkB/IRR receptor chimera promotes survival of sympathetic neurons through Ras and PI-3 kinase signalingKaren S Kelly-Spratt, Laura J Klesse, Luis F Parada
Molecular and Cellular Neurosciences|February 22, 2003
Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factorsRomke Bron, Laura J Klesse, Kirti Shah, et al.
JID Innovations : Skin Science From Molecules to Population Health|October 4, 2021
Insights into the Pathogenesis of NF1-Associated NeoplasmsAshley Bui, Chunhui Jiang, Renee M McKay, et al.
Journal of Neuro-Oncology|August 10, 2016
Postoperative surveillance of pediatric cerebellar pilocytic astrocytomaRaphael Alford, Lynn Gargan, Daniel C Bowers, et al.
Children (Basel, Switzerland)|March 6, 2021
Risk Factors for Bullying Victimization in Children with Neurofibromatosis Type 1 (NF1)Peter L Stavinoha, Cody Solesbee, Susan M Swearer, et al.
CA: a Cancer Journal for Clinicians|April 1, 2021
Recent progress in the treatment of cancer in childrenErin Butler, Kathleen Ludwig, Holly L Pacenta, et al.
School Psychology (Washington, D.C.)|November 8, 2019
Rate and frequency of bullying victimization in school-age children with neurofibromatosis type 1 (NF1)Alice Ann Holland, Peter L Stavinoha, Susan M Swearer, et al.
Pageof 4